Difference between revisions of "Pharm Meeting Agenda 2021.03.17"
Jump to navigation
Jump to search
| Line 17: | Line 17: | ||
:* CP-PHARM-145 Cross-community PHARM-1 (CMPD profile) | :* CP-PHARM-145 Cross-community PHARM-1 (CMPD profile) | ||
:* CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile) | :* CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile) | ||
| − | :* CP-PHARM-147 moodCode for patient-reported medications (MTP | + | :* CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles) |
For information only: | For information only: | ||
Revision as of 11:12, 11 March 2021
Meeting details
Location
Agenda
Q1 13:00- 14:30 Change proposals & Medication Lists
Change Proposals
- CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
- CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
- CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
- CP-PHARM-145 Cross-community PHARM-1 (CMPD profile)
- CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile)
- CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
For information only:
- CP-ITI-xxx "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
- CP-PCC-xxx Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles